Industry Briefs: Apr. 23, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
3M Drug Delivery Systems has expanded its pressurized metered dose inhaler fill line at its facility in Northridge, California.
Baxter International will invest $1 billion over the next five years for a new manufacturing facility in Georgia for plasma-derived therapies.
Eisai has amended its license agreement with Teikoku Pharma USA for the Aricept transdermal patch system.
Kemwell Biopharma has expanded its pharmaceutical development laboratories, including a 7500-ft2 cGMP pilot facility, in Bangalore, India, to support pharmaceutical projects from preformulation to finished products.
Merck Millipore, the life-science division of Merck KGaA, has announced the schedule for the Merck Millipore Live Lab Tour 2012 that will visit nine science parks and institutions in Europe during May–June 2012. Click
Mylan is expanding its operations in Dublin and Galway, Ireland.
Patheon has formed Patheon Certified Consultants, a new consulting services comprised of industry professionals to assist emerging biotechnology and pharmaceutical companies.
West Pharmaceutical Services has dedicated new cleanroom manufacturing capabilities at its Scottsdale, Arizona, pharmaceutical delivery systems engineering center. West will manufacture its Daikyo Crystal Zenith 1-mL long prefillable syringe system at the Scottsdale facility.
People News
AMRI has appointed Christopher Conway and Louis Garguilo as vice-president in its business-development units.
Novasep has appointed Jean-Claude Romain as corporate quality director and Alain Lamproye as director of the company’s bioproduction sites in Belgium.
Quintiles has named Tom Pike as CEO.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
